Protection of flupirtine on β-amyloid-induced apoptosis in neuronal cells in vitro: Prevention of amyloid-induced glutathione depletion

Journal of Neurochemistry

Volumn 68, Issue 6, 1997, Pages 2371-2377

  Müller, Werner E G ^a   Romero, Francisco J ^c   Perovic, Sanja ^a,d   Pergande, Gabriela ^b   Pialoglou, Periklis ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b ASTA MEDICA AG   (Germany)

^c UNIVERSITY OF VALENCIA   (Spain)

^d RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

Alzheimer's disease; Amyloid; Amyotrophic lateral sclerosis; Flupirtine; Oxidative stress; Triaminopyridine

Indexed keywords

AMYLOID BETA PROTEIN; FLUPIRTINE; GLUTATHIONE;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL PROTECTION; DNA DEGRADATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

EID: 1842371505     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.68062371.x     Document Type: Article

References (55)

1. Alzheimer A. (1907) Über eine eigenartige Erkrankung der Hirnrinde Zentralbl. Nervenheilk. Psychiatr. 18, 177-179.
2. Bansal N., Houle A., and Melnykovych G. (1991) Apoptosis: mode of cell death induced in T cell leukemia lines by dexamethasone and other reagents. FASEB J. 5, 211-216.
3. Barrow C. J., Yasuda A., Kenny P. T. M., and Zagorski M. G. (1992) Solution conformations and aggregational properties of synthetic amyloid β-peptides of Alzheimer's disease. J. Mol. Biol. 225, 1075-1093.
4. Benzi G. and Moretti A. (1995) Are reactive oxygen species involved in Alzheimer's disease? Neurobiol. Aging 16, 661-674.
5. Block F., Pergande G., and Schwarz M. (1994) Flupirtine protects against ischemic retinal dysfunction in rats. Neuroreport 5, 2630-2632.
6. Block F., Pergande G., and Schwarz M. (1995) Flupirtine reduces functional and morphological consequences induced by global ischemia in rats. Eur. J. Neurosci. (Suppl.) 8, 24.
7. Bredesen D. E. (1994) Neuronal apoptosis: genetic and biochemical modulation, in Apoptosis II: The Molecular Basis of Apoptosis in Disease (Tomei L. D. and Cope F. O., eds). pp. 397-421. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
8. Chandrasekaran K., Stoll L., Brady D. R., and Rapoport S. I. (1992) Distribution of cytochrome oxidase (COX) activity and mRNA in monkey and human brain. COX mRNA distribution correlates with neurons vulnerable to Alzheimer pathology. Soc. Neurosci. Abstr. 18, 557.
9. Cordell B. (1994) β-Amyloid formation as a potential therapeutic target for Alzheimer's disease. Annu. Rev. Pharmacol. Toxicol. 34, 69-89.
10. Dyrks T., Dyrks E., Hartmann T., Masters C. L., and Beyreuther K. (1993) Radicals as mediators for the amyloidogenic transformation of βA4-bearing APP fragments, in Alzheimer's Disease: Advances in Clinical and Basic Research (Corain B., Iqbal K., Nicolini M., Winblad B., Wisniewski H., and Zatta P., eds), pp. 497-506. Wiley, Chichester.
11. Friedel H. A. and Fitton A. (1993) Flupirtine: a review of its pharmacological properties, and therapeutic efficacy in pain patients. Drug 45, 548-569.
12. Gavrieli Y., Sherman Y., and Den-Sasson S. A. (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119, 493-501.
13. Glenner G. G. and Wong C. W. (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885-890.
14. Goetz M. E., Freyberger A., Hauer E., Burger E., Sofic E., Gsell W., Heckers S., Jellinger K., Hebenstreit G., Froehlich L., Beckmann H., and Riederer P. (1992) Susceptibility of brains from patients with Alzheimer's disease to oxygen-stimulated lipid peroxidation and differential scanning calorimetry. Dementia 3, 213-222.
15. Hardy J. and Allsop D. (1991) Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol. Sci. 12, 383-386.
16. Harman D. (1996) A hypothesis on the pathogenesis of Alzheimer's disease. Ann. NY Acad. Sci. 786, 152-168.
17. Hensley K., Aksenova M., Carney J. M., Harris M., and Butterfield D. A. (1995) Amyloid beta-peptide spin trapping. II. Evidence for the decomposition of the PBN adduct. Neuroreport 6, 493-496.
18. Hlavica P. and Niebch G. (1985) Untersuchungen zur Pharmakokinetik und Biotransformation des Analgetikums Flupirtin beim Menschen. Arzneimittelforschung 35, 42-49.
19. Hockenbery D. M., Oltvai Z. N., Yin M. X., Milliman C. L., and Korsmeyer S. J. (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75, 241-251.
20. Jaendel C., Nicolas M. B., Dubois F., Nabet-Belleville F., Penin F., and Cuny G. (1989) Lipid peroxidation and free radical scavengers in Alzheimer's disease. Gerontology 35, 275-282.
21. Kang J., Lemaire H. G., Unterbeck A., Salbaum J. M., Masters C. L., Crzeschick K. H., Multhaup G., Beyreuther K., and Müller-Hill B. (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733-736.
22. Koh J., Yang L. L., and Cotman C. W. (1990) β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res. 533, 315-320.
23. Lee V. M. Y. and Trojanowski J. Q. (1995) Tau proteins and their significance in the pathobiology of Alzheimer's disease, in Pathobiology of Alzheimer's Disease (Goate A. M. and Ashall F., eds), pp. 41-58. Academic Press, London.
24. Loo D. T., Copani A., Pike C. J., Whitemore E. R., Walencewicz A. J., and Cotman C. W. (1993) Apoptosis is induced by β-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. USA 90, 7951-7955.
25. Maier-Lenz H. and Thieme G. (1983) Kumulationskinetik von Flupirtin (D 9998) bei oraler Applikation. Forschungsbericht Asta-Medica, Frankfurt.
26. Masters C. L., Multhaup G., Simms G., Pottgiesser J., Martins R. N., and Beyreuther K. (1985) Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzhcimer's disease contain the same protein as the amyloid of the plaque cores and blood vessels. EMBO J. 4, 2757-2763.
27. Maurer K., Ihl R., and Frölich L. (1993) Alzheimer. Springer, Berlin.
28. McMahon F. G., Arndt W. F., Newton J. J., Montgomery P. A., and Perhach J. L. (1987) Clinical experience with flupirtine in the U.S. Postgrad. Med. J. 63, 81-85.
29. Mecocci P., MacGarvey U., and Beal U. (1994) Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol. 36, 747-751.
30. Mueller W. E. G., Schroeder H. C., Ushijima H., Dapper J., and Bormann J. (1992) Gp120 of HIV-1 induces apoptosis in rat cortical cell cultures: prevention by memantine. Eur. J. Pharmacol. 226, 209-214.
31. Mueller W. E. G., Ushijima H., Schroeder H. C., Forrest J., Shatton W. H. F., Rytik P. G., and Heffner-Lauc M. (1993) Cytoprotective effect of N-methyl-D-aspartate receptor antagonists on prion protein (Prion-Sc)-induced toxicity in rat cortical cell culture. Eur. J. Pharmacol. 246, 261-267.
32. Mullan M. and Crawford F. (1993) Genetic and molecular advances in Alzheimer's disease. Trends Neurosci. 16, 398-403.
33. Obermeier K., Niebich G., and Thiemer K. (1985) Untersuchungen zur Pharmakokinetik und Biotransformation des Analgetikums Flupirtin bei Ratte und Hund. Arzneimittelforschung 35, 60-67.
34. Oliver C. N., Ahn B. W., Moerman E. J., Goldstein S., and Stadtman E. R. (1987) Age-related changes in oxidized proteins. J. Biol. Chem. 262, 5488-5491.
35. Osborne N. N., Pergande G., Block F., and Schwarz M. (1994) Immunohistochemical evidence for flupirtine acting as an antagonist on the N-methyl-D-aspartate (NMDA) and homocysteic acid-induced release of GABA in the rabbit retina. Brain Res. 667, 291-294.
36. Osborne N. N., Schwarz M., and Pergande G. (1996) Protection of rabbit retina from ischemia injury by flupirtine. Invest. Ophthalmol. Vis. Sci. 37, 274-280.
37. Perovic S., Schleger C., Pergande G., Iskric S., Ushijima H., Rytik P., and Müller W. E. G. (1994) The triaminopyridine flupirtine prevents cell death in rat cortical cells induced by N-methyl-D-aspartate and gp120 of HIV-1. Eur. J. Pharmacol. 288, 27-33.
38. Pike C. J., Burdick D., Walencewicz A. J., Glabe C. G., and Cotman C. W. (1993) Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13, 1676-1687.
39. Ratan R. P. and Baraban J. M. (1995) Apoptotic death in an in vitro model of neuronal oxidative stress. Clin. Exp. Pharmacol. Physiol. 22, 309-310.
40. Reed D. J., Babson J. R., Beatty P. W., Brodie A. E., Ellis W. W., and Potter D. W. (1980) High-performance liquid chromatography analysis of nanomole levels of glutathione, glutathione disulfide, and related disulfides. Anal. Biochem. 106, 55-62.
41. Romero F. J. (1996) Antioxidants in peripheral nerve. Free Radic. Biol. Med. 20, 925-932.
42. Rosen D. R., Siddique T., Patterson D., Figlewicz D. A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J. P., and Deng H. X. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59-62.
43. Rothstein J. D., Bristol L. A., Hosler B., Brown R. H., and Kuncl R. W. (1994) Chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons. Proc. Natl. Acad. Sci. USA 91, 4155-4159.
44. 2+ concentrations. Eur. J. Pharmacol. 294, 469-473.
45. Sachs L. (1984) Angewandte Statistik. Springer. Berlin.
46. Scudiero D. A., Shoemaker R. H., Paull K. D., Monks A., Tierney S., Nofziger T. H., Currens M. J., Seniff D., and Boyd M. R. (1988) Evaluation of a tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 48, 4827-4833.
47. Szelenyi I., Nickel B., Borbe H. O., and Brune K. (1989) Mode of antinociceptive action of flupirtine in the rat. Br. J. Pharmacol. 97, 835-842.
48. Tariot P. N., Cohen R. M., Sunderland T., Newhouse P. A., Yount D., Mellow A. W., Weingartner H., Mueller E. A., and Murphy D. L. (1987) Preliminary evidence for behavioral change with monoamine oxidase B inhibition. Arch. Gen. Psychiatry 44, 427-433.
49. Terry R D., Masliah E., Salmon D. P., Butters N., DeTeresa R., Hill R., Hansen L. A., and Katzman R. (1991) Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate to cognitive impairment. Ann. Neurol. 30, 572-580.
50. Ushijima H., Nishio O., Klöcking R., Perovic S., and Mueller W. E. G. (1995) Exposure to gp120 of HIV-1 induces an increased release of arachidonic acid in rat primary neuronal cell culture followed by NMDA receptor mediated neurotoxicity. Eur. J. Neurosci. 7, 1353-1359.
51. von Bebenburg W., Engel J., and Sheldrik W. S. (1981) Synthese und Molekülstruktur des konstitutionell neuartigen Analgetikums Flupirtin. Chemiker-Ztg. 105, 217-219.
52. Williams L. R. (1995) Oxidative stress, age-related neurodegeneration. and the potential for neurotrophic treatment. Cerebrovasc. Brain Metab. Rev. 7, 55-73.
53. Wyllie A. H. (1980) Glucocorticoid-induced thymocyte apoptosis is associated with endogenous nuclease activation. Nature 284, 555-556.
54. Yankner B A., Dawes L. R., Fisher S., Villa-Komaroff L., Oster-Granite M. L., and Neve R. L. (1989) Cytotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 245, 417-420.
55. Yates C. M., Butterworth J., Tennant M. C., and Gordon A. (1990) Enzyme activities in relation to pH and lactate in postmortem brain in Alzheimer-type and other dementias. J. Neurochem. 55, 1624-1630.